Lamotrigine (Lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial

Pain

Volumn 73, Issue 2, 1997, Pages 223-230

  Zakrzewska, Joanna M ^a   Chaudhry, Zareena ^b   Nurmikko, Turo J ^c   Patton, David W ^d   Mullens, E Lynette ^e  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d MORRISTON HOSPITAL   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Lamotrigine; Randomised controlled trial; Trigeminal neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; PLACEBO;

ANALGESIA; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; TRIGEMINUS NEURALGIA;

ADULT; AGED; ANALGESICS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TRIAZINES; TRIGEMINAL NEURALGIA;

EID: 0030810189     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00104-8     Document Type: Article

References (15)

1. Barker II F.G., Jannetta P.J., Bissonette D.J., Larkins M.V., Jho M.D. The long-term outcome of microvascular decompression for trigeminal neuralgia. N. Engl. J. Med. 334:1996;1077-1083.
2. Betts T., Goodwin G., Withers R.M., Yuen A.W.C. Human safety of lamotrigine. Epilepsia. 32(Suppl. 2):1991;S17-S21.
3. Brodie, M.J., Richens, A. and Yuen, A.W.C. (for UK lamotrigine/carbamazepine monotherapy trial group), Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy, Lancet, 345 (1995) 476-479.
4. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
5. Fields H.L. Treatment of trigeminal neuralgia. N. Engl. J. Med. 334:1996;1125-1126.
6. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1:1975;277-279.
7. Melzack R., Terrence C., Fromm G., Amsel R. Trigeminal neuralgia and atypical facial pain: use of the McGill Pain Questionnaire for discrimination and diagnosis. Pain. 27:1986;297-302.
8. Patsalos, P.N., Medical management. In: J.M. Zakrzewska (Ed.), Trigeminal Neuralgia. A Practical Approach to Management, Major Problems in Neurology Series, Vol. 28, W.B. Saunders, London, 1995, pp. 80-107.
9. Reunanen M., Dam M., Yuen A.W.C. A randomised open multicenter comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res. 23:1996;149-155.
10. Steiner, T.J., Silveira, C., Yuen, A.W.C. and the North Thames Lamictal Study Group, Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy, Epilepsia, 35 (7) (1994) 61.
11. Whitehead, J., The Design and Analysis of Sequential Clinical Trials, Wiley, New York, 1992.
12. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
13. + channels in rat hippocampal neurones. Pflugers Arch. Eur. J. Physiol. 430:1995;437-446.
14. Zakrzewska J.M., Patsalos P.N. Drugs used in the management of trigeminal neuralgia. Oral Surg. Oral Med. Oral Pathol. 74:1992;439-450.
15. Zakrzewska, J.M., Trigeminal Neuralgia. A Practical Approach to Management, Major Problems in Neurology Series, Vol. 28, W.B. Saunders, London, 1995.